PowerUp Acquisition stock soars to all-time high of $15.15

Published 12/02/2025, 15:46
PowerUp Acquisition stock soars to all-time high of $15.15

In a remarkable display of market confidence, PowerUp Acquisition Corp. (PWUPU) stock has surged to an all-time high, reaching $15.15, with a market capitalization of $108.8 million. According to InvestingPro analysis, the stock appears to be trading above its Fair Value, with a "FAIR" overall financial health rating. This significant milestone underscores the company’s robust performance and investor optimism. Over the past year, PowerUp Acquisition has witnessed an impressive 21.36% gain, complemented by a strong year-to-date return of 16.7%. This growth trajectory has rewarded long-term investors, though InvestingPro subscribers can access 8 additional key tips about the company’s performance and financial health. The stock’s momentum has positioned it as a notable player in its sector, with particularly strong price momentum scores according to InvestingPro metrics.

In other recent news, PowerUp Acquisition Corp. has gained shareholder approval for its merger with Aspire Biopharma, Inc., with a substantial 92.8% of the issued and outstanding Class A ordinary shares supporting the merger. The merger, anticipated to conclude by February 17, 2025, will result in the formation of Aspire Biopharma Holdings, Inc., which is expected to trade on the Nasdaq Stock Market.

In addition to the merger approval, shareholders voted in favor of several related proposals, including increasing authorized share capital, amending bylaws, and electing directors for staggered terms. PowerUp’s domestication to Delaware and a name change post-merger were also approved. An incentive plan for Aspire Biopharma Holdings, Inc. employees and directors received approval as well.

Before the meeting, shareholders elected for the redemption of 507,631 Class A ordinary shares, leading to approximately $5.8 million being removed from PowerUp’s trust account. These recent developments mark a significant shift for PowerUp Acquisition Corp. as it prepares for its future as Aspire Biopharma Holdings, Inc.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.